These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16154857

  • 1. Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old.
    Italiano A, Jardin F, Peyrade F, Saudes L, Tilly H, Thyss A.
    Haematologica; 2005 Sep; 90(9):1281-3. PubMed ID: 16154857
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Spina M, Simonelli C, Tirelli U.
    J Clin Oncol; 2007 Feb 20; 25(6):e7. PubMed ID: 17308261
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy].
    Malliti M, Junot H, Fievet MH, Gabarre J, Taright N, Vernant JP, Thuillier A.
    Ann Med Interne (Paris); 2003 May 20; 154(3):139-47. PubMed ID: 12910040
    [Abstract] [Full Text] [Related]

  • 4. Retrospective comparison between CHOP-PVP and CHOP protocols for non-Hodgkin's lymphoma.
    Gan H, Zhang F, Lin Y.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul 20; 24(4):397-9. PubMed ID: 12408775
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 20; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
    van Agthoven M, Wittebol S, Budel LM, Uyl-de Groot CA, Kramer MH.
    Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):88-93. PubMed ID: 14753131
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
    Yuan ZY, Xu RH, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr 10; 22(4):393-6. PubMed ID: 12703996
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R, Hagenbeek A.
    Eur J Haematol Suppl; 2007 Jan 10; (67):5-14. PubMed ID: 17206982
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New treatment options have changed the survival of patients with follicular lymphoma.
    Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP.
    J Clin Oncol; 2005 Nov 20; 23(33):8447-52. PubMed ID: 16230674
    [Abstract] [Full Text] [Related]

  • 19. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 20; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 20. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma.
    Shabbat S, Aharoni J, Sarid L, Ben-Harush M, Kapelushnik J.
    Pediatr Blood Cancer; 2009 May 20; 52(5):664-6. PubMed ID: 19142990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.